aTyr Pharma Inc.

NASDAQ: LIFE · Real-Time Price · USD
1.90
0.05 (2.70%)
At close: Jun 04, 2024, 8:00 PM

aTyr Pharma Statistics

Share Statistics

aTyr Pharma has 69.01M shares outstanding. The number of shares has increased by 0% in one year.

69.01M
0%
0%
n/a
n/a
45,711
9.5%

Short Selling Information

n/a
n/a
n/a
n/a

Valuation Ratios

The PE ratio is -1.5 and the forward PE ratio is null. aTyr Pharma's PEG ratio is 0.04.

-1.5
n/a
214.12
n/a
0.83
-2.02
0.04
Financial Ratio History

Enterprise Valuation

aTyr Pharma has an Enterprise Value (EV) of 68.14M.

193.02
-1.31
-2.05
-1.82

Financial Position

The company has a current ratio of 6.27, with a Debt / Equity ratio of 0.17.

6.27
11.03
0.17
-0.29
-0.4
0

Financial Efficiency

Return on Equity is -55.58% and Return on Invested Capital is -51.92%.

-55.58%
-41.28%
-51.92%
$6,303.57
$-899,803.57
56
0
-0.04

Taxes

-8K
0.02%

Stock Price Statistics

The stock price has increased by 18.75% in the last 52 weeks. The beta is 1.19, so aTyr Pharma's price volatility has been higher than the market average.

1.19
18.75%
1.73
1.59
39.57
480,976

Income Statement

In the last 12 months, aTyr Pharma had revenue of 353K and earned -50.39M in profits. Earnings per share was -0.94.

353K
-2.39M
-54.92M
-50.39M
-52.18M
n/a
-0.94
Full Income Statement

Balance Sheet

The company has 22.54M in cash and 15.1M in debt, giving a net cash position of 7.45M.

22.54M
15.1M
7.45M
-468.02M
113.25M
80.94M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -33.22M and capital expenditures -4.21M, giving a free cash flow of -37.44M.

-33.22M
-4.21M
-37.44M
-0.7
Full Cash Flow Statement

Margins

Gross margin is -676.49%, with operating and profit margins of -15557.79% and -14274.5%.

-676.49%
-15557.79%
-14276.77%
-14274.5%
-14781.3%
-15557.79%
-10605.1%

Dividends & Yields

LIFE does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
-66.67%
-49.53%
Dividend Details

Analyst Forecast

The average price target for LIFE is $35, which is 1742.1% higher than the current price. The consensus rating is "Buy".

$35
1742.1%
Buy
1
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Jul 1, 2019. It was a backward split with a ratio of 1:14.

Jul 1, 2019
backward
1:14

Scores

-4.1
1